Because the amyloid β-peptide (Aβ) functions as approximately half of the transmembrane
domain of the amyloid precursor protein and interaction of Aβ with membranes is proposed …

The amyloid-β (Aβ) peptide is a key aggregate species in Alzheimer's disease. Although
important aspects of Aβ peptide aggregation are understood, the initial stage of aggregation …

The etiology of Alzheimer's disease is considered to be linked to interactions between
amyloid β‐peptide (Aβ) and neural cell membranes. Membrane disruption and increased …

Interactions of β-amyloid (Aβ) peptides with neuronal membranes have been associated
with the pathogenesis of Alzheimer's disease (AD); however, the molecular details remain …

The etiology of Alzheimer's disease is thought to be linked to interactions between amyloid-β
(Aβ) and neural cell membranes, causing membrane disruption and increased ion …

The amyloid β-peptides (Aβs), containing 39–43 residues, are the key protein components
of amyloid deposits in Alzheimer's disease. To structurally characterize the dynamic …

Numerous studies have concluded that the interaction of the amyloid β-peptide (Aβ) and
cellular membranes contributes to the toxicity and cell death observed in the progression of …

Aggregation of amyloid beta (Aβ) peptides in neuronal membranes is a known promoter of
Alzheimer's disease. To gain insight into the molecular details of Aβ peptide aggregation …

Aβ25–35 is a short, cytotoxic, and naturally occurring fragment of the Alzheimer's Aβ
peptide. To map the molecular mechanism of Aβ25–35 binding to the zwitterionic …

Fibrillar aggregates of misfolded amyloid proteins are involved in a variety of diseases such
as Alzheimer disease (AD), type 2 diabetes, Parkinson, Huntington and prion-related …